1. References
  2. Other resources
  • Alsterholm, M., Karami, N. and Faergemann, J. (2010) Antimicrobial activity of topical skin pharmaceuticals – an in vitro study. Acta Derm Venereol 90, 239245.
  • Bartolommei, G., Tadini-Buoninsegni, F., Hua, S., Moncelli, M.R., Inesi, G. and Guidelli, R. (2006) Clotrimazole inhibits the Ca2+-ATPase (SERCA) by interfering with Ca2+ binding and favoring the E2 conformation. J Biol Chem 281, 95479551.
  • Benzaquen, L.R., Brugnara, C., Byers, H.R., Gattoni-Celli, S. and Halperin, J.A. (1995) Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat Med 1, 534540.
  • Bilensoy, E., Rouf, M., Vural, I. and Hincal, A. (2006) Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin. J Control Release 116, e107e109.
  • Brugnara, C. and De Franceschi, L. (2006) Clinical trials of new therapeutic pharmacology for sickle cell disease. Sante 16, 263268.
  • Brugnara, C., Gee, B., Armsby, C.C., Kurth, S., Sakamoto, M., Rifai, N., Alper, S.L. and Platt, O.S. (1996) Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 97, 12271234.
  • Costa, C., Nunes, J., Henriques, A., Mira, N.P., Nakayama, H., Chibana, H. and Teixeira, M.C. (2014) Candida glabrata drug: H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis. J Antimicrob Chemother. doi:10.1093/jac/dku1044. [Epub ahead of print].
  • Cudmore, S.L., Delgaty, K.L., Hayward-McClelland, S.F., Petrin, D.P. and Garber, G.E. (2004) Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev 17, 783793.
  • Eaton, D.R. and Wilkins, R.G. (1978) Reduction by dithionite ion of adducts of metmyoglobin with imidazole, pyridine, and derivatives. J Biol Chem 253, 908915.
  • Eaton, D. and Wilson, K. (1979) Reaction of imidazole and hydroquinone with oxymyoglobin. J Inorg Biochem 10, 195203.
  • Eliel, E.L., Wilen, S.H. and Mander, L.N.(eds) (1994) . Stereochemistry of organic compounds. p. 381. New York: John Wiley and Sons.
  • Ellepola, A. and Samaranayake, L. (2000) Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 11, 172198.
  • Gbotosho, O.T., Cytlak, U.M., Hannemann, A., Rees, D.C., Tewari, S. and Gibson, J.S. (2013) Inhibitors of second messenger pathways and Ca-induced exposure of phosphatidylserine in red blood cells of patients with sickle cell disease. Pflugers Arch. doi:10.1007/s00424-00013-01343-00428. [Epub ahead of print].
  • Gelone, S.A. and O'Donnell, J. (2006) Anti infectives. In Remington the science and practice of pharmacy, 21st Edition ed. Troy, D.B., pp. 16261684. Baltimore: Lippincott Williams and Wilkins.
  • Gemma, S., Campiani, G., Butini, S., Kukreja, G., Joshi, B.P., Persico, M., Catalanotti, B., Novellino, E. et al. (2007) Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore. J Med Chem 50, 595598.
  • Gemma, S., Campiani, G., Butini, S., Kukreja, G., Coccone, S.S., Joshi, B.P., Persico, M., Nacci, V. et al. (2008) Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure–activity relationship studies. J Med Chem 51, 12781294.
  • Hicks, R.G. (2007) What's new in stable radical chemistry? Org Biomol Chem 5, 13211338.
  • Hitchcock, C.A., Dickinson, K., Brown, S., Evans, E. and Adams, D. (1990) Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans. Biochem J 266, 475480.
  • Jan, C.-R., Tseng, C.-J., Chou, K.-J. and Chiang, H.-T. (2000) Novel effects of clotrimazole on Ca2+ signaling in Madin Darby canine kidney cells. Life Sci 66, 22892296.
  • Kalb, R. and Grossman, M. (1985) Contact dermatitis to clotrimazole. Cutis 36, 240242.
  • Lorand, T. and Kocsis, B. (2007) Recent advances in antifungal agents. Mini-Rev Med Chem 7, 900911.
  • Malani, A.N. and Kauffman, C.A. (2007) Changing epidemiology of rare mould infections. Drugs 67, 18031812.
  • Marichal, P., Gorrens, J. and Coene, M. (1990) Biochemical basis for the activity and selectivity of oral antifungal drugs. Br J Clin Pract Suppl 71, 4146.
  • Mishra, N., Prasad, T., Sharma, N., Payasi, A., Prasad, R., Gupta, D. and Singh, R. (2007) Pathogenicity and drug resistance in Candida albicans and other yeast species. Acta Microbiol Immunol Hung 54, 201235.
  • Navarro, M., Peña, N.P., Colmenares, I., González, T., Arsenak, M. and Taylor, P. (2006) Synthesis and characterization of new palladium–clotrimazole and palladium–chloroquine complexes showing cytotoxicity for tumor cell lines in vitro. J Inorg Biochem 100, 152157.
  • Navarro, M., Higuera-Padilla, A.R., Arsenak, M. and Taylor, P. (2009) Synthesis, characterization, DNA interaction studies and anticancer activity of platinum–clotrimazole complexes. Transition Met Chem 34, 869875.
  • Navas, J.M., Chana, A., Herradón, B. and Segner, H. (2004) Induction of cytochrome P4501A (CYP1A) by clotrimazole, a non-planar aromatic compound. Computational studies on structural features of clotrimazole and related imidazole derivatives. Life Sci 76, 699714.
  • Odds, F.C., Brown, A.J. and Gow, N.A. (2003) Antifungal agents: mechanisms of action. Trends Microbiol 11, 272279.
  • OSPAR Commission (2005) Hazardous Substance Series: Open background documentation on clotrimazole; publication no 2005/199. Available at: (accessed 10 June 2014).
  • Oyama, T.M., Oyama, T.B., Oyama, K., Matsui, H., Horimoto, K., Nishimura, Y. and Oyama, Y. (2006) Clotrimazole, an antifungal drug possessing diverse actions, increases the vulnerability to cadmium in lymphocytes dissociated from rat thymus. Toxicology 228, 269279.
  • Pasqualotto, A.C., Thiele, K.O. and Goldani, L.Z. (2010) Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole. Curr Opin Investig Drugs, 11, 165174.
  • Pelletier, R., Peter, J., Antin, C., Gonzalez, C., Wood, L. and Walsh, T.J. (2000) Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations. J Clin Microbiol 38, 15631568.
  • Podust, L.M., Poulos, T.L. and Waterman, M.R. (2001) Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci 98, 30683073.
  • Porsbring, T., Blanck, H., Tjellström, H. and Backhaus, T. (2009) The pharmaceutical clotrimazole affects marine microalgal communities at picomolar concentrations. In SETAC Europe 19th Annual Meeting, Gothenburg, Sweden. http://swepubkbse/bib/swepub:oai:servicessciglooorg:113304?tab2=abs&language=en.
  • Rittenhouse, A., Vandorpe, D., Brugnara, C. and Alper, S. (1997) The antifungal imidazole clotrimazole and its major in vivo metabolite are potent blockers of the calcium-activated potassium channel in murine erythroleukemia cells. J Membr Biol 157, 177191.
  • Robles-Escajeda, E., Martínez, A., Varela-Ramirez, A., Sánchez-Delgado, R.A. and Aguilera, R.J. (2013) Analysis of the cytotoxic effects of ruthenium–ketoconazole and ruthenium–clotrimazole complexes on cancer cells. Cell Biol Toxicol 29, 431443.
  • Santos, S.S., Lorenzoni, A., Pegoraro, N.S., Denardi, L.B., Alves, S.H., Schaffazick, S.R. and Cruz, L. (2014) Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole. Colloids Surf B Biointerfaces 116c, 270276.
  • Shah, M., Miscony, Z., Javadzadeh-Tabatabaie, M., Ganellin, C. and Haylett, D. (2001) Clotrimazole analogues: effective blockers of the slow afterhyperpolarization in cultured rat hippocampal pyramidal neurones. Br J Pharmacol 132, 889898.
  • Singh, S., Jain, S., Muthu, M., Tiwari, S. and Tilak, R. (2008) Preparation and evaluation of buccal bioadhesive films containing clotrimazole. AAPS PharmSciTech 9, 660667.
  • Sobel, J.D. (2007) Vulvovaginal candidosis. Lancet 369, 19611971.
  • Song, H. and Shin, H.-S. (1998) The antifungal drug clotrimazole. Acta Crystallogr Sect C: Cryst Struct Commun 54, 16751677.
  • Sweetman, S.C.(eds) (2007) . Martindale: the complete drug reference. p. 764. London: Pharmaceutical Press.
  • Thapa, D., Lee, J.S., Park, M.-A., Cho, M.-Y., Park, Y.-J., Choi, H.G., Jeong, T.C. and Kim, J.-A. (2009) Inhibitory effects of clotrimazole on TNF-α-induced adhesion molecule expression and angiogenesis. Arch Pharm Res 32, 593603.
  • Tian, M., Dong, M.Q., Chiu, S.W., Lau, C.P. and Li, G.R. (2006) Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents. Br J Pharmacol 147, 289297.
  • Tiffert, T., Ginsburg, H., Krugliak, M., Elford, B.C. and Lew, V.L. (2000) Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum. Proc Natl Acad Sci 97, 331336.
  • Tonglairoum, P., Ngawhirunpat, T., Rojanarata, T., Kaomongkolgit, R. and Opanasopit, P. (2014) Fast-acting clotrimazole composited PVP/HPbetaCD nanofibers for oral candidiasis application. Pharm Res. doi:10.1007/s11095-11013-11291-11091. [Epub ahead of print].
  • Trivedi, V., Chand, P., Srivastava, K., Puri, S.K., Maulik, P.R. and Bandyopadhyay, U. (2005) Clotrimazole inhibits hemoperoxidase of Plasmodium falciparum and induces oxidative stress. Proposed antimalarial mechanism of clotrimazole. J Biol Chem 280, 4112941136.
  • Valerio, C., Perillo, T., Brescia, L. and Russo, F. (2013) Antifungal agents in current pediatric practice. Curr Infect Dis Rep 15, 278287.
  • Vanić, Ž. and Škalko-Basnet, N. (2013) Nanopharmaceuticals for improved topical vaginal therapy: can they deliver? Eur J Pharm Sci 50, 2941.
  • Weig, M. and Brown, A.J. (2007) Genomics and the development of new diagnostics and anti-Candida drugs. Trends Microbiol 15, 310317.
  • White, T.C., Holleman, S., Dy, F., Mirels, L.F. and Stevens, D.A. (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46, 17041713.
  • Wu, S.N., Li, H.F., Jan, C.R. and Shen, A.Y. (1999) Inhibition of Ca2+ activated K+ current by clotrimazole in rat anterior pituitary GH3 cells. Neuropharmacology 38, 979989.

Other resources

  1. References
  2. Other resources
  • Chemical Drawing package used: MarvinSketch ver. 4.1.13. for Macintosh Downloadable from